RIGging cellular immunity: New RNA based anti-cancer strategy

Item Number: 609
Industry: Therapeutic
Category: Immunology, Oncology
Development Stage: Early Stage
Organisation Type: Government Institute
Country: South Korea
Patent: Korea, PCT, USA
Business Opportunity: Out-Licensing, Collaboration R&D


The researchers demonstrated that expression of these optimized RNA molecules induced immunogenic cell death in cancer cells, but not in non-cancer cells

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it